Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jun;9(6):813-24.
doi: 10.1586/ern.09.21.

Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis

Affiliations
Review

Development of the calcium plateau following status epilepticus: role of calcium in epileptogenesis

Nisha Nagarkatti et al. Expert Rev Neurother. 2009 Jun.

Abstract

Status epilepticus is a clinical emergency defined as continuous seizure activity or rapid, recurrent seizures without regaining consciousness and can lead to the development of acquired epilepsy, characterized by spontaneous, recurrent seizures. Understanding epileptogenesis--the transformation of healthy brain tissue into hyperexcitable neuronal networks--is an important challenge and the elucidation of molecular mechanisms can lend insight into new therapeutic targets to halt this progression. It has been demonstrated that intracellular calcium increases during status epilepticus and that these elevations are maintained past the duration of the injury (Ca(2+) plateau). As an important second messenger, Ca(2+) elevations can lead to changes in gene expression, neurotransmitter release and plasticity. Thus, characterization of the post-injury Ca(2+) plateau may be important in eventually understanding the pathophysiology of epileptogenesis and preventing the progression to chronic epilepsy after brain injury.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure

The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Figures

Figure 1
Figure 1. Alterations in intracellular Ca2+ concentration immediately following 3 h of low Mg2+-induced in vitro SE
(A) Representative whole-cell current-clamp electrophysiological recording obtained from a control neuron and a neuron in low Mg2+ or in vitro SE. The neuron in low Mg2+ shows epileptiform discharges at a frequency greater than 3 Hz. By contrast, the control neuron shows action potentials intermittently, consistent with baseline firing activity. (B) Bar graph comparing fura-2 340/380 ratios in control neurons versus neurons immediately following 3 h of low Mg2+. The low Mg2+-treated cells exhibit ratio values of 1.4 ± 0.17 as compared with the control neurons with values of 0.20 ± 0.04 (data expressed as mean ± standard error of the mean). (C) Representative pseudocolor ratio images obtained from control (left panel) and low Mg2+-treated (right panel) neurons. Neurons from the low Mg2+ group show an increased 340/380 ratio immediately following treatment. SEM: Status epilepticus. (A) reproduced with permission from [83].
Figure 2
Figure 2. SE causes increased [Ca2+]i acutely in the in vivo pilocarpine model
(A) Representative EEG recording from control (vehicle) rats and rats in pilocarpine-induced SE. (B) Bar graph demonstrating that [Ca2+]i is higher in neurons from animals immediately following SE when compared with those from animals in the control group: 850 ± 59 nM and 90 ± 22 nM, respectively (data expressed as mean ± standard error of the mean). [Ca2+]i: Intracellular Ca2+ concentration. (A) reproduced with permission from [90] and (B) adapted with permission from [32].
Figure 3
Figure 3. The Ca2+ plateau following SE
At one day post-SE, ([Ca2+]i) are significantly elevated when compared with controls, 790 ± 43 nM and 98 ± 10 nM, respectively (all data expressed as mean ± standard error of the mean). A total of 2 days post-SE the [Ca2+]i is 684 ± 47 nM, which is significantly higher than the 96 ± 14 nM observed in the control. At 6 days following SE, the [Ca2+]i is still markedly elevated when compared with controls, yet has fallen slightly from earlier timepoints, 475 ± 36 nM and 100 ± 10 nM, respectively. [Ca2+]i falls slightly at 10 days post-SE to 395 ± 56 nM but is still significantly elevated when compared with the controls with [Ca2+]i of 95 ± 14 nM. Finally, at 30 days post-SE the [Ca2+]i is 361 ± 28 nM versus 106 ± 16 nM in controls. The persistent elevation in [Ca2+]i represents the Ca2+ plateau. [Ca2+]i: Intracellular Ca2+ concentration; SE: Status epilepticus. Adapted with permission from [32].
Figure 4
Figure 4. Acquired epilepsy is associated with alterations in [Ca2+]i and Ca2+ homeostatic mechanisms 24 h post-in vitro SE
(A) Electrophysiological traces using current-clamp technique demonstrate baseline activity in control neurons and SREDs in neurons that had been treated in low Mg2+ for 3 h and then returned to normal maintenance media. Resting membrane potential = -61.5 mV; duration of shown trace = 30 min. (B) Bar graph comparing 340/380 ratio values in control versus SE groups 24 h after treatment with Mg2+-containing buffer solution or low Mg2+, respectively. Neurons in the SE group exhibit a 340/380 ratio of 0.5 ± 0.08 (mean ratio ± standard error of the mean). The ratio from control group neurons is significantly lower at 0.20 ± 0.05. (C) Glutamate stimulation causes increased [Ca2+]i. Peak ratios following glutamate are normalized to 1.0. Recovery from this challenge is hindered in epileptic neurons when compared with controls. [Ca2+]i: Intracellular Ca2+ concentration; SE: Status epilepticus; SRED: Spontaneous, recurrent epileptiform discharge. (A) reproduced with permission from [83] and (B) reproduced with permission from [37].
Figure 5
Figure 5. Acquired epilepsy is associated with alterations in [Ca2+]i and Ca2+ homeostatic mechanisms one year post-in vivo status epilepticus (SE)
(A) Representative EEG recording from control (vehicle) rats and epileptic rats (following pilocarpine-induced SE). (B) Bar graph with neurons from epileptic animals at 1 year post-SE demonstrating [Ca2+]i of 325 ± 35 nM (data represented as mean ± standard error of the mean), which is significantly higher than neurons from control group. (C) Upon glutamate stimulation, the [Ca2+]i increases and then returns to baseline in neurons from the control group, unlike neurons from the epileptic group which also peak but then fail to return to baseline. [Ca2+]i: Intracellular Ca2+ concentration. (B) adapted with permission from [32] and (C) reproduced with permission from [35].

Similar articles

Cited by

References

    1. Delorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther. 2005;105(3):229–266. - PMC - PubMed
    1. Willmore LJ. Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia. 1990;31(Suppl. 3):S67–S73. - PubMed
    1. Cavalheiro EA, Leite JP, Bortolotto ZA, et al. Long-term effects of pilocarpine in rats: structural damage of the brain triggers kindling and spontaneous recurrent seizures. Epilepsia. 1991;32(6):778–782. - PubMed
    1. Lothman EW, Bertram EH., 3rd Epileptogenic effects of status epilepticus. Epilepsia. 1993;34(Suppl. 1):S59–S70. - PubMed
    1. Hesdorffer DC, Logroscino G, Cascino G, Annegers JF, Hauser WA. Risk of unprovoked seizure after acute symptomatic seizure: effect of status epilepticus. Ann Neurol. 1998;44(6):908–912. - PubMed

Website

    1. Internet Stroke Center at Washington Univ. in St. Louis. The Stroke Trials Registry. www.strokecenter.org/trials/InterventionDetail.aspx?tid=95.

Publication types